News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Personnel
New Chairman Appointed At Egenix, Inc. 12/19/2014
Dr. Tanya Mayadas Joins Biothera's Research Advisory Board 12/19/2014
BTG plc (BTG.L): Appointment Of Non-Executive Director 12/19/2014
Tekmira (TKMR) Announces Leadership Changes 12/19/2014
Takeda (TKPYY) Snatches Sanofi (SAN.PA) Exec To Lead Global R&D 12/18/2014
Daxor Corporation (DXR) Appoints Michael Feldschuh As Executive Vice President 12/18/2014
MonoSolRx LLC Names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall Assumes Role Of CEO 12/18/2014
Chimerix, Inc. (CMRX) Appoints Ronald C. Renaud, Jr. To Board Of Directors 12/18/2014
Dr. Michael A Ross, MD, Appointed As CEO Of Euclid Systems Corporation 12/18/2014
Pacific Biosciences (PACB) Appoints Kathy Ordonez To Board Of Directors 12/18/2014
Raptor Pharmaceutical Inc. (RPTP) Appoints Gregg Lapointe And Georges Gemayel To Board Of Directors 12/18/2014
Celldex Therapeutics, Inc. (CLDX) Announces Appointment To Board Of Directors 12/18/2014
Claritas Genomics Appoints Patrick F. Terry As Chief Commercial Officer 12/18/2014
Protagonist Therapeutics Names William A. Hodder As Senior Vice President, Corporate Development 12/18/2014
PDS Biotechnology Corporation Announces Appointment Of Biotech Industry Leader Sir Richard Sykes To Its Board Of Directors As Executive Chairman 12/18/2014
Verastem, Inc. (VSTM) Appoints Daniel Paterson As Chief Operating Officer 12/18/2014
Dicerna Pharmaceuticals (DRNA) Announces The Appointment Of Theodore T. Ashburn, M.D., Ph.D. To Senior Vice President, Product Strategy And Operations, And Inducement Grant Of Stock Options Under NASDAQ Listing Rule 5635 (C)(4) 12/18/2014
Alnylam Pharmaceuticals (ALNY) Elects Michael W. Bonney To Its Board Of Directors 12/18/2014
Actavis (ACT) Purges Most Allergan (AGN) Execs In Takeover 12/17/2014
Gilead Sciences, Inc. (GILD) Poaches Genentech (RHHBY) Exec To Head Cancer Drug Program 12/17/2014
United Therapeutics Corporation (UTHR) Cuts Top Executive's Pay; Names Co-CEO 12/17/2014
EXCLUSIVE: Express Scripts Inc. CFO Out After Clashes With CEO 12/17/2014
TG Therapeutics, Inc. (MHA) Announces Appointment Of Kenneth Hoberman To Board Of Directors 12/17/2014
Catalyst Pharmaceuticals (CPRX) Announces The Passing Of Hubert E. Huckel, Co-Founder And Director 12/17/2014
Merrimack Pharmaceuticals Inc. (MACK) Announces The Addition Of Russell T. Ray To Its Board Of Directors 12/17/2014
Vermillion Names Valerie Palmieri CEO; James Lafrance To Continue As Chairman Of Board 12/17/2014
Kinex Pharmaceuticals Appoints Chief Operating Officer 12/17/2014
Inovio Pharmaceuticals (INO) Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014
Appointment Of Dr Kenneth Newman As Chief Medical Officer And Incorporation Of Verona Pharma (VRP.L) 12/17/2014
Integrated Environmental Technologies, Ltd. Expands Board Of Directors 12/17/2014
IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute For Healthcare Informatics 12/17/2014
Trevena, Inc. (TRVN) Appoints Anne M. Phillips To The Board Of Directors 12/17/2014
Renowned Geneticist Altshuler Ditches The Broad Institute For Vertex Pharmaceuticals (MA) (VRTX) 12/16/2014
Ex-Onyx Pharmaceuticals, Inc. (ONXX) CEO Leads MA Biotech Startup 12/16/2014
Genentech (RHHBY)'s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot 12/16/2014
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi As Chief Commercial Officer 12/16/2014
Industry Expert David Schneider Joins Comprehend Board Of Directors 12/16/2014
Relypsa, Inc. (RLYP) Announces Stephen D. Harrison, M.A., Ph.D., Joins As Senior Vice President And Chief Scientific Officer 12/16/2014
Applied Proteomics, Inc. Appoints Steve R. Martin As Chief Financial Officer 12/16/2014
Actavis (ACT) Announces Proposed Senior Leadership Team Effective Following Completion Of Allergan (AGN) Acquisition 12/16/2014
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman Of New Scientific Advisory Board 12/16/2014
SRI International Names Luther Lau Chief Financial Officer 12/16/2014
Gil Beyen Joins Novadip Biosciences Board Of Directors 12/16/2014
Ceres, Inc. Announces Changes To Board Of Directors 12/16/2014
Smithers Viscient Delivers Business Improvements As Head Of Chemistry Appointed 12/16/2014
François Garnier Appointed Executive Vice President, General Counsel Of Ipsen (IPN.PA) 12/16/2014
Antibe Therapeutics Inc. Announces Appointment Of US-Based Investor Relations Consultant 12/16/2014
ZS Genetics, Inc., Developer Of A Unique And Potentially Disruptive “Third-Generation” DNA Sequencing Technology Platform, Announces Organization Change To Accelerate Strategic Plans 12/16/2014
Atossa Genetics, Inc. (ATOS) Hires Pieter van der Poel As Vice President Of European Commercial Operations 12/16/2014
Biova LLC Names New President, Introduces New COO 12/16/2014
Genocea Biosciences Appoints Eric S. Hoffman As Chief Business Officer 12/15/2014
Heart Failure Society of America Announces New Editor-in-Chief 12/15/2014
Aurora Algae Appoints Paul Angelico As President And CEO 12/15/2014
Ex-Wyeth (WYE) Head Out Of The Running For Sanofi (SAN.PA) CEO Gig 12/15/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Appoints John H. Johnson To Board Of Directors 12/15/2014
Lion Biotechnologies, Inc. Names Elma Hawkins President, CEO, And Director 12/15/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Several Key Additions To Management Team 12/15/2014
Apricus Biosciences (APRI) Appoints Barbara Troupin, M.D. As Chief Medical Officer 12/15/2014
AeroScout Founder Joins GlassesOff's Board Of Directors 12/15/2014
Aptose Biosciences Announces Appointment Of Dr. Erich Platzer To Board Of Directors 12/15/2014
Immune Pharmaceuticals, Inc. Elects Daniel Kazado As New Chairman Of The Board 12/15/2014
Epizyme (EPZM) Elects Kenneth Bate To Board Of Directors 12/15/2014
Atox Bio Announces Appointment Of Biotech Veteran Daniel D. Burgess As Chairman Of The Board 12/15/2014
Insmed Incorporated (INSM) Appoints Myrtle Potter To Its Board Of Directors 12/15/2014
BioTime (BTX) Appoints Angus C. Russell To Board Of Directors 12/15/2014
Abcam Inc. Appoints Yvonne Chien As Chief Digital Officer 12/12/2014
AXIM Biotechnologies Adds World Leaders In Cannabis Research And International Finance To Advisory Board 12/12/2014
Vermillion Strengthens Board Of Directors With Appointments Of Veronica Jordan, Ph.D., And David Schreiber 12/12/2014
Virginia Bio Welcomes Two New Members To Its Board Of Directors 12/12/2014
Acceleron Pharma Appoints Dr. Francois Nader To Its Board Of Directors 12/12/2014
Changes In Roche (RHHBY) Board Of Directors And Enlarged Corporate Executive Committee 12/12/2014
Abcam plc (ABC.L) Board Appointment 12/12/2014
GUEST COLUMN: Does Size Kill Culture? Prothena Doesn’t Think So 12/12/2014
Mylan Inc. (MYL) To Pay Five Top Execs $32.5 Million Earlier Than Planned As Drugmaker Exits U.S. 12/11/2014
Biotech CEO Of Health Decisions Dies In Plane Crash 12/11/2014
Amarantus BioSciences, Inc. Appoints Elise Brownell, Ph.D., As Senior Vice President Of Operations And Project Management 12/11/2014
Rhythm Appoints Fred T. Fiedorek, M.D., Chief Medical Officer 12/11/2014
Illinois Biotechnology Industry Organization Makes Notable Additions To Board Of Directors 12/11/2014
Pathway Genomics Corporation Adds The Honorable Dan Glickman, Former U.S. Cabinet Member And Member Of Congress, To Strategic Advisory Board 12/11/2014
OvaScience (OVAS) Strengthens Management Team To Support Expanding Global Operations 12/11/2014
Dr. Haim Danenberg Joins CBSET As Chief Scientific Adviser 12/11/2014
Agios Pharmaceuticals (AGIO) Appoints Kaye Foster-Cheek To Its Board Of Directors 12/10/2014
Parnell Pharmaceuticals Holdings Announces Key Senior Management and Director Appointments 12/10/2014
Soligenix (SNGX) Appoints Oreola Donini, PhD, As Chief Scientific Officer 12/10/2014
Relmada Therapeutics Appoints Christine Silverstein As Director Of Investor Relations 12/10/2014
Parenteral Drug Association Announces Board Of Directors Election Results 12/10/2014
N-of-One Expands Executive Team To Meet Market Demand 12/10/2014
Concert Pharmaceuticals, Inc. (CNCE) Names Thomas Auchincloss To Board Of Directors And Chair Of The Audit Committee 12/10/2014
Versant Ventures Strengthens Biotechnology Investment Team In North America And Europe 12/10/2014
New Addition To NOXXON Pharma AG Supervisory Board Brings Significant U.S. Public Market Expertise 12/10/2014
Cytovance Biologics Inc. Appoints Don Wuchterl As Chief Operating Officer 12/10/2014
Dr. Boris Kuvshinoff Named Chief Medical Quality Officer, Interim Chief Medical Officer At Roswell Park Cancer Institute 12/9/2014
N-of-One Expands Executive Team To Meet Market Demand 12/9/2014
Corium International, Inc. Announces Appointment Of Ivan Gergel, M.D. To Board Of Directors 12/9/2014
INC Research, Inc. (INCR) Appoints Pharmaceutical Industry Veteran Richard Kender To Board Of Directors 12/9/2014
Arcturus Therapeutics Announces The Appointment Of Michael R. Hodges, M.D. To The Scientific Advisory Board 12/9/2014
Sanford I. Weill Retires As Chair Of The Weill Cornell Medical College Board Of Overseers After 20 Years Of Transformative Leadership 12/9/2014
Eurofins Scientific Release: Expands Microbiology Division In California 12/9/2014
Pharnext Announces The Nomination Of Michel De Rosen, A Pharmaceutical And Biotechnology Industry Leader, To Its Board Of Directors 12/9/2014
Corium International, Inc. Announces Appointment Of Ivan Gergel, M.D. To Board Of Directors 12/9/2014
Sanford I. Weill Retires As Chair Of The Weill Cornell Medical College Board Of Overseers After 20 Years Of Transformative Leadership 12/9/2014
Prime Therapeutics Joins The National Association Of Specialty Pharmacy (NASP) As A Founding Corporate Member 12/9/2014
Fresenius Kabi AG Announces 2014 Inductees For Fenwal Blood Donation Hall Of Fame 12/9/2014
Aquinox Pharmaceuticals (AQXP) Announces Appointment Of Mr. David C. Mitchell As Vice President, Global Regulatory Affairs & Quality Assurance 12/9/2014
Beyondspring Pharmaceuticals Names Dr. Yan Sun As Principal Investigator For Global Phase 3 Lung Cancer Clinical Trial Of Plinabulin 12/9/2014
Ex-Sanofi (SAN.PA) Employee Claims Ousted CEO Of $34M Kickback Scheme 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
ATS Labs Announces New Name And Introduces New CEO 12/8/2014
Glenn Foundation For Medical Research Welcomes Dr. Kevin Lee As Senior Advisor 12/8/2014
Leidos Names Steven Russell Senior Vice President For Sales And Strategic Accounts 12/8/2014
Organovo Appoints Dr. Kirk Malloy To Board Of Directors 12/8/2014
XTL Biopharmaceuticals Ltd. (XTLB) Appoints Dr. Jonathan Schapiro MD And Dr. Dobroslav Melamed To The Board Of Directors To Help Lead Development Of Its Clinical Assets 12/8/2014
Amarantus BioSciences, Inc. Appoints Renowned Drug Development Expert And Co-Founder Of Amgen (AMGN), Joseph Rubinfeld, Ph.D., To Its Board Of Directors 12/8/2014
Peter Kant Joins SRI International As Executive Director Of SRI's Center For Science, Technology, And Economic Development 12/8/2014
Batu Biologics Appoints Gerry Berg As Chief Financial Officer 12/8/2014
Bench International Inc. Extends Team In Major Life Science Hubs 12/8/2014
PROMETHERA Biosciences S.A./N.V. Appoints Dr John Tchelingerian As The New Chairman Of The Board 12/8/2014
Innocoll Appoints Tony Zook As CEO As Company Progresses Toward Becoming A Fully-Integrated Commercial Company 12/8/2014
NeuroVive Pharmaceutical AB Employs a Clinical Trial Manager 12/8/2014
Nutra Pharma Corp. (NPHC) Letter To Shareholders 12/8/2014
Lannett Company, Inc. (LCI) Names Michael Bogda As President 12/5/2014
Paratek Pharmaceuticals, Inc. Announces Appointment Of Douglas Pagan As Chief Financial Officer 12/5/2014
Bellicum Pharmaceuticals, Inc. Announces New Director, Executive Management Appointments 12/5/2014
Proteo Biotech AG (PTEO.OB) Expands Management Board 12/5/2014
Arno Therapeutics Appoints Alexander Zukiwski, M.D. To Board Of Directors 12/5/2014
Evofem, Inc. Appoints Chad Putnam As Chief Financial Officer 12/5/2014
Arrowhead Research Corporation (ARWR) Appoints Patrick O’Brien As General Counsel 12/5/2014
Synta Pharmaceuticals (SNTA) Strengthens Management Team With Two Executive Appointments 12/5/2014
Cesca Therapeutics Appoints Mr. Denis Michael Rhein To Its Board Of Directors 12/5/2014
Cara Therapeutics, Inc. (CARA) Announces Appointment Of Joseph Stauffer, D.O., As Chief Medical Officer 12/5/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Appointment Of Robert A. Doody Jr. As Vice President Of Investor Relations And Corporate Communications 12/5/2014
Heat Biologics Expands Product Development Team To Support Development Of Lead Product Candidates In Oncology 12/5/2014
Calithera Biosciences, Inc. (CALA) Appoints H. Ward Wolff To Board Of Directors 12/5/2014
WIRB-Copernicus Group (WCG) Thought Leaders Tapped For Key Roles At Annual Conference On Research Ethics 12/5/2014
Abingworth Appoints Kurt Von Emster As A Partner In Menlo Park 12/5/2014
Jaguar Animal Health Appoints Former Merial Executive To Head Regulatory Affairs 12/4/2014
Institut Pasteur Appoints Isabelle Buckle, EVP, Research Applications And Industrial Partnerships And Pierre Legrain, EVP, Academic Development & Grant Office To Reinforce Its Partnership Strategy Between Academia And Private Industry 12/4/2014
Ziarco Announces Appointment Of Mike Grey To Board Of Directors 12/4/2014
Ocera Therapeutics, Inc. (OCRX) Promotes Michael Byrnes To Chief Financial Officer 12/4/2014
Biocept, Inc. (BIOC) Appoints Experienced Physician As Medical Director 12/4/2014
Cancer Genetics, Inc. (CGIX) Announces The Appointments Of Dr. Howard Mcleod And Geoffrey Harris To Its Board Of Directors 12/4/2014
SCYNEXIS, Inc. (SCYX) Announces Appointment Of Two Seasoned Industry Professionals To Its Board Of Directors 12/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) Appoints Richard Rodgers To Its Board Of Directors 12/4/2014
Enumeral Biomedical (ENUM) Appoints Robert L. Van Nostrand To Its Board Of Directors 12/4/2014
Pronutria Appoints Dr. Peter Mueller As President Of R&D And Chief Scientific Officer 12/4/2014
Neogen Corporation (NEOG) Names COO 12/4/2014
SOHM Announces Appointing Of Chair Of Advisory Board Team 12/4/2014
Intrexon Corporation Announces The Appointment of Peter Emtage, Ph.D., As Vice President, Synthetic Immunology 12/4/2014
Henry Schein, Inc. (HSIC) Appoints Dr. Lawrence S. Bacow To Its Board of Directors 12/4/2014
CMC Biologics Announces Joseph Wypych, 20 Year Biopharmaceutical Executive, Joins As General Manager Of Seattle Facility 12/4/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Election Of Pharmaceutical Industry Veteran Kevan Clemens To Board Of Directors 12/4/2014
DuPont (DD) Names Matthias Heinzel As President Of Dupont Nutrition & Health Following Retirement Of Craig F. Binetti 12/4/2014
Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione To IBD Advisory Team 12/4/2014
Prothena Corporation plc CEO Diagnosed With Pancreatic Cancer 12/3/2014
Pharma-Bio Serv, Inc. (PBSV.OB) Appoints Víctor Sánchez As President And Chief Executive Officer Effective January 1, 2015 12/3/2014
Afferent Pharmaceuticals Announces The Election Of Dr. Peter Hirth To The Company’s Board Of Directors 12/3/2014
Osiris Therapeutics, Inc. (OSIR) Announces Expansion Of The Leadership Team 12/3/2014
Foundation Medicine, Inc. (FMI) Appoints David J. Daly As Chief Commercial Officer 12/3/2014
Proteostasis Therapeutics, Inc. Announces Appointment Of Dr. Po-Shun Lee As Vice President Of Clinical Development 12/3/2014
Cognoptix Expands Clinical Advisory Board 12/3/2014
ONL Therapeutics Announces Management Team Additions 12/3/2014
DeNovo Sciences Hires Joe Flanagan For Market Development 12/2/2014
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off 12/2/2014
Optio Labs Names Mobile Industry Veteran Gregg Smith As Chief Executive Officer 12/2/2014
Idera Pharmaceuticals, Inc. (IDRA) Names Vincent J. Milano CEO 12/2/2014
Metamark Appoints Dr. Anjen Chenn To Senior Vice President Of Clinical Operations 12/2/2014
Thomas Caskey Joins NextCode Health 12/2/2014
Dimension Therapeutics Expands Leadership Team, Names Eric Crombez, M.D., As Chief Medical Officer 12/2/2014
QLT Inc. (QLTI) Announces Departure Of Chief Financial Officer 12/2/2014
ARCA biopharma Announces Management Transitions 12/2/2014
Apricus Biosciences (APRI) Appoints Brian T. Dorsey As Chief Development Officer 12/2/2014
Tocagen Inc. Appoints Franklin M. Berger, CFA, To The Board Of Directors 12/2/2014
Leonard Schaeffer Joins scPharmaceuticals Board Of Directors 12/2/2014
Marken (Formerly known as Marken Time Critical) Appoints Mark R. Hembarsky To Head North American Region 12/2/2014
Juno Therapeutics Appoints Jeffrey Bluestone As Scientific Advisor 12/2/2014
RaNA Therapeutics, Inc. Appoints Ronald C. Renaud, Jr., As CEO 12/1/2014
Hanwha Chemical Sacks 4 Top Biotech Executives 12/1/2014
NuCana Appoints Dr. Paolo Paoletti To Its Board Of Directors 12/1/2014
BioClinica, Inc. Names Dr. John Hubbard Chief Executive Officer 12/1/2014
Affymax, Inc. (AFFY) Announces A Special Cash Distribution And The Appointment Of A New Director And Chief Executive Officer 12/1/2014
Aridis Pharmaceuticals Appoints Dr. Steven Opal To Scientific Advisory Board 12/1/2014
Biologist Pamela Weathers Elected A Fellow Of The American Association for Advancement of Science 12/1/2014
Industry Expert Dr. Stefan Krawielitzki Reinforces The AVA Group 12/1/2014
Ardelyx Inc. (ARDX) Appoints Jeremy S. Caldwell, Ph.D., As Executive Vice President And Chief Scientific Officer 12/1/2014
SynGen Inc. Hires Former Becton, Dickinson and Company (BDX) Business Development Manager As President Of Cell Processing Business Unit 12/1/2014
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers 12/1/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
Novo Nordisk A/S (NVO) Restructures Executive Board As Chief Of Staff Leaves 11/26/2014
Prof. Yitzhak Peterburg Elected Chairman Of Teva Pharmaceutical Industries Limited (TEVA)’s Board Of Directors 11/26/2014
Joseph Lobacki To Become Medivation, Inc. (MDVN)'s Chief Commercial Officer 11/26/2014
Lundbeck Inc. (LUN.CO) CEO Ulf Wiinberg Resigns After Breach Of Company Rules 11/25/2014
Minerva Neurosciences, Inc. (NERV) Appoints Dr. Remy Luthringer As CEO 11/25/2014
Cellectar Biosciences  (NVLT) Names Cameron Szakacs, Ph.D. Vice President Of Clinical Development 11/25/2014
Juno Therapeutics Appoints Maggie Wilderotter To Board Of Directors 11/25/2014
NeoStem, Inc. CSO Dr. Robert Preti Elected Vice Chairman Of The Alliance for Regenerative Medicine (ARM) 11/25/2014
Spark Therapeutics Appoints Former Chief Of U.S. FDA's Gene Therapy Branch As Its Head Of Regulatory Affairs 11/25/2014
CRF Health Boosts Leadership Team With New Appointments 11/25/2014
Takeda Pharmaceuticals President Doug Cole Quits 11/24/2014
The SEED Partners Appoints Doug Kohrs To Chair Advisory Board 11/24/2014
Arthritis Foundation Selects Michael Ortman As Board Chair 11/24/2014



//-->